Manufacturing Plant
The state-of-the-art Embio manufacturing facility is capable to handle large volume and small volume Active Pharmaceutical Ingredients, advanced intermediates, chiral intermediates and chiral resolving agents. Facility is built and managed as per International Quality Management System.
Facility is approved by US-FDA, PMDA, EMA, KFDA, COFEPRIS, WHO-GMP and ANVISA.
The Mahad plant has been designed to meet the following objectives:
- Small volume and large volume bio transformation processes
- Manufacturing as per ICH Q7 Part 21 guidelines
- International standards EHS compliance
- Reduce carbon footprint
Facility comprises of 7 production blocks which has the capacity to develop and execute a wide range of unit processes and operations.
